INS and delirium: Secondary outcomes included acute length of stay (LOS), delirium severity, antipsychotic use, hospital complications and mortality.<h4>Results</h4>The intention-to-treat analysis included 97 participants [intranasal insulin n = 48, control n = 49; mean (SD) age, 87.6 (7.0) years; 63% female].